Literature DB >> 6875384

Intestinal absorption, excretion, and biotransformation of hyodeoxycholic acid in man.

E Sacquet, M Parquet, M Riottot, A Raizman, P Jarrige, C Huguet, R Infante.   

Abstract

Five patients fitted with a biliary T-tube after cholecystectomy were given orally a tracer dose of [14C]hyodeoxycholic acid and 500 mg of the same unlabeled acid. Intestinal absorption and biotransformation, liver metabolism, bile secretion, fecal and urinary excretions of this acid or of its metabolites were studied. Hyodeoxycholic acid was well absorbed by the human intestine. It was not subjected to intestinal transformations and, particularly, did not produce a significant amount of lithocholic acid, which does not support the existence of intestinal bacterial 6 alpha-dehydroxylases. The percentage of hyodeoxycholic acid and of its metabolites recovered in bile varied from 11.5 to 31%. Two major metabolites were isolated from bile: glycohyodeoxycholic acid and hyodeoxycholic acid glucuronide. Analysis of urinary bile acids showed that a large proportion (30-84%) of the administered hyodeoxycholic acid was excreted by the kidney as a glucuronide. The large extent of both glucuronidation and urinary excretion of hyodeoxycholic acid is a unique example of bile acid metabolism and excretion in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875384

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

2.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.

Authors:  H U Marschall; H Matern; H Wietholtz; B Egestad; S Matern; J Sjövall
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 3.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

4.  A hydrophilic bile acid effects partial dissolution of cholesterol gallstones in the prairie dog.

Authors:  B I Cohen; E H Mosbach; C K McSherry; B Rzigalinski; S Kuroki
Journal:  Lipids       Date:  1986-09       Impact factor: 1.880

5.  Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).

Authors:  E Jacquemin; M Dumont; O Bernard; S Erlinger; M Hadchouel
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

6.  Hydrophilic bile acids: prevention and dissolution experiments in two animal models of cholesterol cholelithiasis.

Authors:  B I Cohen; T Mikami; N Ayyad; A Ohshima; R Infante; E H Mosbach
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

7.  beta-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats.

Authors:  D Gadelle; P Raibaud; E Sacquet
Journal:  Appl Environ Microbiol       Date:  1985-03       Impact factor: 4.792

8.  Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat.

Authors:  M Angelico; L Baiocchi; A Nistri; A Franchitto; P Della Guardia; E Gaudio
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

Review 9.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

10.  Isolation of a Highly Thermostable Bile Salt Hydrolase With Broad Substrate Specificity From Lactobacillus paragasseri.

Authors:  Hiroyuki Kusada; Masanori Arita; Masanori Tohno; Hideyuki Tamaki
Journal:  Front Microbiol       Date:  2022-02-17       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.